DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactResults

AstraZeneca Pharma India Limited — Board Meeting Intimation

NSE 1 hr ago·4 Aug 2026, 5:06 am

Company NSE

AstraZeneca Pharma India has announced a board meeting scheduled for August 10, 2026. The primary agenda for this meeting is to consider and approve the unaudited financial results for the quarter ending June 2026.

This announcement is a routine corporate update that signals the company is nearing the release of its quarterly performance data. For investors, the upcoming results will provide the most recent insight into the company's operational health and financial trajectory.

Market participants should watch for the specific figures released in the results, particularly revenue growth and profit margins. These details will be crucial for assessing the company's current performance and future outlook.